Skip to content
Bramble

Business

PepsiCo lowers 2026 core profit forecast, plans more cost cuts as North America lags

PepsiCo cut its 2026 core earnings-per-share outlook on 8 October, saying recovery in North America is taking longer than planned, and said it would add structural cost cuts. Third-quarter revenue beat expectations.

2 outlets · 0L · 2C · 0R First reported Account updated

Updated (version 2). Rewritten with the latest reporting.

Image: CNA
Image: Anadolu Agency

1 / 2

The story, neutrally told

Centre · 2PepsiCo said on Thursday 8 October that it was lowering its 2026 core earnings-per-share forecast and would pursue additional cost cuts, citing sluggish demand for its snacks and beverages in North America and rising input costs. Centre · 2CNA reported that the company now expects currency-adjusted core EPS to rise 1% to 2%, against a prior forecast of the low end of a 4% to 6% rise; Anadolu Agency reported the new range as 2.5% to 3.5%, against a previous target of the low end of a 5% to 7% range. Centre · 2On revenue, CNA said PepsiCo adjusted its 2026 organic revenue forecast to about 3% from 2% to 4%, while Anadolu said it expects annual net revenue growth of about 6%, at the upper end of prior guidance of 4% to 6%.

Centre · 1Third-quarter results beat expectations: Anadolu reported revenue up 5.6% to $25.27 billion, adjusted EPS of $2.34, net income attributable to PepsiCo of $3.05 billion ($2.23 per share) and organic revenue growth of 3.1%. Centre · 2North America was the weak spot: third-quarter volumes were flat in food and down 2% in beverages, and Chief Financial Officer Steve Schmitt said improving growth and core operating margin was "taking more time than we planned", with North American margin expected to stay under pressure in the fourth quarter. Centre · 1CNA reported that core operating margin fell 35 basis points in the quarter and 25 basis points year to date to 16.5% of revenue, whereas in December, after talks with activist investor Elliott Investment Management, PepsiCo had targeted a 100-basis-point gain over three years.

Centre · 2CEO Ramon Laguarta said "additional structural cost reduction actions are being identified and will be implemented in the coming months" to fund investment in growth and offset input-cost inflation; Anadolu added that he plans to reduce redundancies and discretionary spending and said North America "performed below our expectations". Centre · 1International operations remained stronger, accounting for 41% of revenue so far this year according to Laguarta, and the company is focusing on innovation such as snacks with simpler ingredients and added protein or fiber, functional hydration, energy drinks and zero-sugar beverages. Centre · 1CNA placed the results in a wider context: high input costs, inflation-hit demand, the threat of GLP-1 weight-loss drugs, a turnaround that began after Elliott took a roughly $4 billion stake a year ago, and peers such as General Mills, McCormick and Conagra spending more on promotions.

Centre · 1PepsiCo cut prices by up to 15% on products such as Lay's and Doritos in February but said last month it would raise some chip prices; RBC analyst Nik Modi said beverages "continue to disappoint" and PepsiCo would have to fully refranchise its beverage business or keep losing share. Shares were up about 1% to 2% in premarket trading.

Every sentence links to the reporting it rests on. The pill in front of each says where its sources sit: Left, Centre or Right when one side supplies at least half of them, Mixed when they are evenly split. The number is how many outlets it cites.

Left0 outlets

No left outlet in our sources has covered this story yet.

Centre2 outlets

Framing
Both outlets treat it as a business-results story: a guidance cut driven by North American weakness and input costs, paired with a promise of deeper cost cuts. CNA stresses the pressure on the turnaround and the industry backdrop; Anadolu stresses the quarterly numbers and international strength.
Emphasis
CNA: North America margin pressure, Elliott's stake, GLP-1 drugs, analyst criticism, peers. Anadolu: revenue and earnings figures, the 41% international share, product innovation.
Leaves out or plays down
Anadolu omits Elliott, GLP-1 drugs, margin figures and the analyst comment; CNA's shorter piece omits quarterly results and its longer piece omits net income. The two give different guidance figures that neither explains.
Charged language
“persistent pain point”“continues to disappoint”
For example
“PepsiCo warned on Thursday that growth and margin recovery in its key North American market was taking longer than planned” — CNA
“Food and beverage giant lowers 2026 core earnings growth forecast to 2.5%-3.5% despite higher quarterly revenue” — Anadolu Agency

Right0 outlets

No right outlet in our sources has covered this story yet.